Diamond Biotechnology Co., Ltd
Diamond Biotechnology Co., Ltd researches, develops, manufactures, and sells medical equipment and skincare products in Taiwan and internationally. The company offers skin care products under the Timera and Diamond Beauty brands. It also leases medical equipment. Diamond Biotechnology Co., Ltd was founded in 2014 and is based in Taipei, Taiwan.
Market Cap & Net Worth: Diamond Biotechnology Co., Ltd (6815)
Diamond Biotechnology Co., Ltd (TWO:6815) has a market capitalization of $55.68 Million (NT$1.84 Billion) as of March 19, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #21465 globally and #1178 in its home market, demonstrating a -8.71% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diamond Biotechnology Co., Ltd's stock price NT$46.65 by its total outstanding shares 39493001 (39.49 Million).
Diamond Biotechnology Co., Ltd Market Cap History: 2026 to 2026
Diamond Biotechnology Co., Ltd's market capitalization history from 2026 to 2026. Data shows growth from $55.68 Million to $55.68 Million (0.00% CAGR).
Diamond Biotechnology Co., Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diamond Biotechnology Co., Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6815 by Market Capitalization
Companies near Diamond Biotechnology Co., Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Diamond Biotechnology Co., Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Diamond Biotechnology Co., Ltd Historical Marketcap From 2026 to 2026
Between 2026 and today, Diamond Biotechnology Co., Ltd's market cap moved from $55.68 Million to $ 55.68 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$55.68 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Diamond Biotechnology Co., Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $55.68 Million USD |
| MoneyControl | $55.68 Million USD |
| MarketWatch | $55.68 Million USD |
| marketcap.company | $55.68 Million USD |
| Reuters | $55.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.